Advertisement

Diagnosis of Age-Related Macular Degeneration

  • Jonathan Jonisch
  • Gaurav Shah
Chapter

Abstract

Classifying AMD helps physicians counsel patients, make treatment decisions, and standardize clinical trials. The presentation of AMD can vary widely and thus the differential diagnosis is large. Medical and ocular history, ophthalmoscopy, and ancillary testing can be used in combination to narrow the differential diagnosis. When the response to standard therapy is not typical, the diagnosis of AMD may need to be revisited.

Keywords

Retinal Pigment Epithelial Fluorescein Angiography Geographic Atrophy Retinal Angiomatous Proliferation Pigment Epithelial Detachment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, et al. The Framingham Eye Study II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol. 1977;106(1):33–41.PubMedGoogle Scholar
  2. 2.
    Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol. 1960;63:587–615.Google Scholar
  3. 3.
    Russell SR, Mullins RF, et al. Location, substructure, and composition of basal laminar drusen compared with drusen associated with age-related macular degeneration. Am J Ophthalmol. 2000;129:205–14.PubMedCrossRefGoogle Scholar
  4. 4.
    Abdelsalam A, Del Priore L, Zarbin MA. Drusen in age-related macular degeneration: pathogenesis, ­natural course, and laser photocoagulation-induced regression. Surv Ophthalmol. 1999;44(1):1–29. Review.PubMedCrossRefGoogle Scholar
  5. 5.
    Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973;90(3):206–17.PubMedGoogle Scholar
  6. 6.
    Green WR, McDonnell PJ, Yeo JH. Pathologic features of senile macular degeneration. Ophthalmology. 1985;92(5):615–27.PubMedGoogle Scholar
  7. 7.
    Sarks SH. Council lecture. Drusen and their relationship to senile macular degeneration. Aust J Ophthalmol. 1980;8(2):117–30.PubMedCrossRefGoogle Scholar
  8. 8.
    Holz FG, Wolfensberger TJ, Piguet B, Gross-Jendroska M, Wells JA, Minassian DC, et al. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology. 1994;101(9):1522–8.PubMedGoogle Scholar
  9. 9.
    Spraul CW, Grossniklaus HE. Characteristics of Drusen and Bruch’s membrane in postmortem eyes with age-related macular degeneration. Arch Ophthalmol. 1997;115(2):267–73.PubMedGoogle Scholar
  10. 10.
    Gass JD. Stereoscopic atlas of macular disease: diagnosis and treatment. 4th ed. St. Louis: Mosby; 1997.Google Scholar
  11. 11.
    Lim JI. Age-related macular degeneration. New York: Marcel Dekkar, Inc.; 2002.CrossRefGoogle Scholar
  12. 12.
    Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104(1):7–21.PubMedGoogle Scholar
  13. 13.
    Klein ML, Mauldin WM, Stoumbos VD. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol. 1994;112(7):932–7.PubMedGoogle Scholar
  14. 14.
    Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol. 1997;115(6):741–7.Google Scholar
  15. 15.
    Ferris 3rd FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102(11):1640–2.PubMedGoogle Scholar
  16. 16.
    Sunness JS, Gonzalez-Baron J, Applegate CA, Bressler NM, Tian Y, Hawkins B, et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology. 1999;106(9):1768–79.PubMedCrossRefGoogle Scholar
  17. 17.
    Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol. 1993;111(9):1189–99.Google Scholar
  18. 18.
    Bressler NM, Frost LA, Bressler SB, Murphy RP, Fine SL. Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophthalmol. 1988;106(11):1537–42.PubMedGoogle Scholar
  19. 19.
    Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-­related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39:367–74.PubMedCrossRefGoogle Scholar
  20. 20.
    Klein R, Klein BE, Linton KL. Prevalence of age-­related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99(6):933–43.PubMedGoogle Scholar
  21. 21.
    The Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol. 2001;132:668–81.CrossRefGoogle Scholar
  22. 22.
    Jager RD, Mieler WF, Mille JW. Age-related macular degeneration. N Engl J Med. 2008;358:2606–17.PubMedCrossRefGoogle Scholar
  23. 23.
    Green WR, Gass JDM. Senile disciform degeneration of the macula. Arch Ophthalmol. 1971;100:487–94.Google Scholar
  24. 24.
    Green WR, Enger C. Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman lecture. Ophthalmology. 1993;100:1519–35.PubMedGoogle Scholar
  25. 25.
    Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416–34.PubMedCrossRefGoogle Scholar
  26. 26.
    Borrillo JL, Sivalingam A, Martidis A, et al. Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol. 2003;121:558–61.PubMedCrossRefGoogle Scholar
  27. 27.
    Fernandes LH, Freund KB, Yannuzzi LA, et al. The nature of focal areas of hyperfluorescence or hot spots imaged with indocyanine green angiography. Retina. 2002;22:557–68.PubMedCrossRefGoogle Scholar
  28. 28.
    Stern RM, Zakov N, Zegarra H, et al. Multiple recurrent serous sanguineous retinal pigment epithelial detachments in black women. Am J Ophthalmol. 1985;100:560–9.PubMedGoogle Scholar
  29. 29.
    Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy. Retina. 1990;10:1–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Laude A, Cackett PD, Vithana EN, Yeo IY, Wong D, Koh AH, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res. 2010;29(1):19–29. 2009 Oct 23.PubMedCrossRefGoogle Scholar
  31. 31.
    Yannuzzi LA, Ciardella AP, Spaide RF, et al. The expanding clinical spectrum of idiopathic polypoidal vasculopathy. Arch Ophthalmol. 1997;115:478–85.PubMedGoogle Scholar
  32. 32.
    Perkovich PT, Zakov N, Berlin LA, et al. An update on multiple recurrent serosanguineous retinal pigment epithelium detachments in black women. Retina. 1990;10:18–26.PubMedCrossRefGoogle Scholar
  33. 33.
    Lafaut BA, Leyes AM, Snyders B, et al. Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol. 2000;238:752–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Uyama M, Wada M, Nagai Y, et al. Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol. 2002;133:639–48.PubMedCrossRefGoogle Scholar
  35. 35.
    Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy. Nippon Ganka Gakkai Zasshi. 2005;109:417–27.Google Scholar
  36. 36.
    Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, et al. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology. 2004;111:1576–84.PubMedCrossRefGoogle Scholar
  37. 37.
    Sunness JS, Rubin GS, Applegate CA, Bressler NM, Marsh MJ, Hawkins BS, et al. Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. Ophthalmology. 1997;104(10):1677–91.PubMedGoogle Scholar
  38. 38.
    Steinmetz RL, Haimovici R, Jubb C, Fitzke FW, Bird AC. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch’s membrane change. Br J Ophthalmol. 1993;77(9):549–54.PubMedCrossRefGoogle Scholar
  39. 39.
    Fine AM, Elman MJ, Ebert JE, Prestia PA, Starr JS, Fine SL. Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol. 1986;104(4):513–4.PubMedGoogle Scholar
  40. 40.
    Bressler NM, Munoz B, Maguire MG, Vitale SE, Schein OD, Taylor HR, et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol. 1995;113(3):301–8.PubMedGoogle Scholar
  41. 41.
    Sunness JS, Gonzalez-Baron J, Bressler NM, Hawkins B, Applegate CA. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology. 1999;106(5):910–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Yannuzzi LA, Shakin JL, Fisher YL, et al. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology. 1984;91:1554–72.PubMedGoogle Scholar
  43. 43.
    Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103:2070–9; discussion 2079–80.PubMedGoogle Scholar
  44. 44.
    Spaide RF, Hall LS, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina. 1996;16:203–13.PubMedCrossRefGoogle Scholar
  45. 45.
    Marmor MF. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1988;226:548–52.PubMedCrossRefGoogle Scholar
  46. 46.
    Tittl MK, Spaide RF, Wong D, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol. 1999;128:63–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Yoshida T, Ohno-Matsui K, Ohtake Y, et al. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology. 2003;110(7):1297–305.PubMedCrossRefGoogle Scholar
  48. 48.
    Johnson DA, Yannuzzi LA, Shakin JL, et al. Lacquer cracks following laser treatment of choroidal neovascularization in pathologic myopia. Retina. 1998;18:118–24.PubMedCrossRefGoogle Scholar
  49. 49.
    Armstrong JD, Meyer D, Xu S, et al. Long-term follow up of Stargardt’s disease and fundus flavimaculatus. Ophthalmology. 1998;105:448–58.PubMedCrossRefGoogle Scholar
  50. 50.
    Weleber RG. Stargardt’s macular dystrophy. Arch Ophthalmol. 1994;112:752–4.PubMedGoogle Scholar
  51. 51.
    Marmor MF, Byers B. Pattern dystrophy of the pigment epithelium. Am J Ophthalmol. 1977;84:32–44.PubMedGoogle Scholar
  52. 52.
    Hsieh RC, Fine BS, Lyons JS. Patterned dystrophies of the retinal pigment epithelium. Arch Ophthalmol. 1977;95:429–35.PubMedGoogle Scholar
  53. 53.
    Patrinely JR, Lewis RA, Font RL. Foveomacular vitelliform dystrophy, adult type. A clinicopathologic study including electron microscopic observations. Ophthalmology. 1985;92:1712–8.PubMedGoogle Scholar
  54. 54.
    Jaffe GJ, Schatz H. Histopathologic features of adult-onset foveomacular pigment epithelial dystrophy. Arch Ophthalmol. 1988;106:958–60.PubMedGoogle Scholar
  55. 55.
    Kim DD, Mieler WF, Wolf MD. Posterior segment changes in membranoproliferative glomerulonephritis. Am J Ophthalmol. 1992;114(5):593–9.PubMedGoogle Scholar
  56. 56.
    Clarkson JG, Altman RD. Angioid streaks. Surv Ophthalmol. 1982;26:235–46.PubMedCrossRefGoogle Scholar
  57. 57.
    Lim JI, Bressler NM, Marsh MJ, et al. Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol. 1993;116:414–23.PubMedGoogle Scholar
  58. 58.
    Ho AC, Yannuzzi LA, Pisicano K, et al. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology. 1995;102:782–9.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Barnes Retina InstituteSt. LouisUSA
  2. 2.Barnes Retina InstituteSt. LouisUSA

Personalised recommendations